Lupin partners with ERN to launch Luforbec® in Spain

8 Jun 2026via NSE FilingSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Lupin partners with ERN to launch Luforbec® in Spain. Lupin Limited has announced a collaboration with ERN to launch Luforbec® (beclometasone/formoterol) pMDI in Spain. The product is indicated for asthma and COPD management. This marks Lupin’s strategic expansion into the European respiratory market.

📊 STOCKS: LUPIN | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma

#Pharma#Partnership#Launch

Stocks mentioned

LUPINLUPIN

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →